Clinical trial · Interventional
Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery
Effect of Reversed Tracking Method of Stimulating Cricothyroid Muscles on the Identification and Protection of EBSLN in Thyroid Surgery
NCT03680222CI-TRIAL-00035714unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The feasibility and effectiveness of Reversed Tracking Method for the identification and protection of extralaryngeal nerve branches in thyroid surgery were analyzed. Evidence-based medical evidence was used to evaluate the importance of EBSLN recognition and protection in thyroid surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Recurrent Laryngeal Nerve Injuries | — | UNRESOLVED | — |
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Reversed Tracking Method | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Standard method
- description
- Standard method recommended by the guide
- type
- EXPERIMENTAL
- label
- Reversed Tracking Method
- description
- Reversed Tracking Method
- interventionNames
- Procedure: Reversed Tracking Method
Primary outcomes (1)
- measure
- The identification rate of the external branch of the superior laryngeal nerve.
- timeFrame
- up to 6 months postoperatively
- description
- The identification rate of the external branch of the superior laryngeal nerve.
Secondary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion criteria： 1. thyroid papillary cancer patients 2. thyroid adenoma patients 3. tumor diameter less than 4cm 4. patients who require only unilateral thyroid surgery as required by the guidelines Exclusion criteria: 1. The upper pole tumor invades the anterior dorsum and may accumulate the area of the superior laryngeal nerve; 2. Patients who have previously performed head and neck surgery; 3. Preoperative laryngoscopy and sound assessment abnormalities or previous vocal cord surgery history; 4. If there is a language or hearing impairment, the follow-up assessment cannot be completed; 5. The assessment failure of nerve function due to the technical deficiency of the IONM equipment Elimination criteria: 1. Patients with recurrent laryngeal nerve palsy after surgery affect the evaluation of the laryngeal nerve. 2. The patient is asked to withdraw from the follow-up assessment midway.
References
Publications (0)
Data not yet available
No reference posted for this study.